Treatment Resistant Depression Market to Surpass US$ 1,545.6 Mn by 2030 | AbbVie Inc, Lupin, Pfizer Inc, Sanofi, Viatris
BURLINGAME, CALIFORNIA, UNITED STATES, November 14, 2023 /EINPresswire.com/ -- The Treatment Resistant Depression Market is estimated to be valued at US$ 1,180.0 Mn in 2022 and is expected to exhibit a CAGR of 3.4% over the forecast period 2022-2030, as …